@article{59d95f5fd9a54ee29c65141c2592c68e,
title = "Efficacy and safety of CAR-T cell therapy in minorities",
author = "Astha Thakkar and Michelly Abreu and Kith Pradhan and Sica, \{R. Alejandro\} and Aditi Shastri and Noah Kornblum and Nishi Shah and Ioannis Mantzaris and Kira Gritsman and Eric Feldman and Richard Elkind and Susan Green-Lorenzen and Amit Verma and Ira Braunschweig and Mendel Goldfinger",
note = "Funding Information: We would like to acknowledge all the physician assistants and nurses on the bone marrow transplant and cellular therapy unit for their compassionate care for these patients. These studies were supported by grants from Izzy Englander, Jane and Myles Dempsey Family, Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program and the Leukemia and Lymphoma Society. Funding Information: AV has received research funding from Prelude, BMS, GSK, Incyte, Medpacto, Curis and Eli Lilly and is a scientific advisor for Stelexis, Novartis, Acceleron and Celgene and received honoraria from Stelexis and Janssen and holds equity in Stelexis and Throws Exception. KG has received research funding from ionctura, SA and ADC therapeutics. AS has received honorarium from GLG, Guidepoint, Onclive, consultation fee from Janssen Pharmaceuticals, advisory board fee from Rigel Pharmaceuticals, research funding from Kymera Therapeutics. AT, MA, KP, RAS, NK, NS, IM, EF, SGL, RE, IB and MG have nothing to disclose. ",
year = "2022",
month = jul,
doi = "10.1038/s41409-022-01670-1",
language = "English (US)",
volume = "57",
pages = "1187--1190",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Springer Nature",
number = "7",
}